Protected PCI Study
NCT02831881 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 369
Last updated 2016-07-13
Summary
A Prospective, multi-center, single-arm post-approval study of the IMPELLA® 2.5 System in Non Emergent High Risk PCI patients.
Conditions
Sponsors & Collaborators
-
Baim Institute for Clinical Research
collaborator OTHER -
Abiomed Inc.
lead INDUSTRY
Principal Investigators
-
William O'Neill, MD · Henry Ford Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-30
- Primary Completion
- 2020-11-30
Countries
- United States
Study Locations
More Related Trials
-
Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein Grafts
NCT00283413 ·Status: COMPLETED ·Phase: NA
-
Carotid Artery Stenting With Protection Registry
NCT00318851 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of a Bioresorbable Coronary Stent
NCT01262703 ·Status: COMPLETED ·Phase: NA
-
LEADERS FREE II: BioFreedom™ Pivotal Study
NCT02843633 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
NCT00231231 ·Status: COMPLETED ·Phase: PHASE3
-
Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool
NCT01383382 ·Status: COMPLETED
-
A Prospective, Non-Randomized, Evaluation of Low-Risk Patients Undergoing Carotid Stenting With ANgiomax (Bivalirudin)
NCT01273350 ·Status: UNKNOWN ·Phase: NA
-
Controlled Arterial Protection to Ultimately Remove Embolic Material
NCT06103591 ·Status: COMPLETED ·Phase: NA
-
PFx Closure System in Subjects With Cryptogenic Stroke,Transient Ischemic Attack,Migraine or Decompression Illness(PFO)
NCT00335296 ·Status: SUSPENDED ·Phase: NA
-
Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)
NCT00287508 ·Status: COMPLETED ·Phase: PHASE4
-
Disrupt CAD III Post-Approval Study (PAS)
NCT05021757 ·Status: COMPLETED
-
Nit-Occlud PDA Post-Approval Study
NCT02100683 ·Status: COMPLETED
-
INSPIRE Pipeline™ Shield Post Approval Study
NCT05071963 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
NCT03103620 ·Status: COMPLETED
-
SORT-OUT VI - Randomized Clinical Comparison of Biomatrix Flex® and Resolute Integrity®
NCT01956448 ·Status: COMPLETED ·Phase: NA
-
RelayPro Thoracic Stent-Graft in Subjects With Thoracic Aortic Aneurysms and Penetrating Atherosclerotic Ulcers
NCT02818972 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)
NCT00316108 ·Status: COMPLETED ·Phase: NA
-
Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent Occlusion
NCT02212626 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D
NCT02900924 ·Status: COMPLETED
-
Shockwave Coronary Lithoplasty® Study (Disrupt CAD II)
NCT03328949 ·Status: COMPLETED ·Phase: NA
-
MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant
NCT00283738 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Prospective Evaluation for Receiving SynFlow 3.0 Interventional Circulatory Support in High-risk PCI: A Randomized Controlled Trial
NCT06853470 ·Status: COMPLETED ·Phase: NA
-
Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I)
NCT02650128 ·Status: COMPLETED ·Phase: NA
-
PREVENT: Promus BTK
NCT01500070 ·Status: COMPLETED ·Phase: PHASE2
-
Protection Against Emboli During Carotid Artery Stenting Using the Neuroguard IEP System
NCT04201132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA